Research Progress of Intestinal Microflora Regulated by Traditional Chinese Medicine in the Treatment of Non-alcoholic Fatty Liver

Authors

  • Shuhan Yang Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China
  • Xiaoni Kou The Second Department of Hepatology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi, China

DOI:

https://doi.org/10.53469/jcmp.2024.06(11).10

Keywords:

Nonalcoholic fatty liver, Intestinal flora, Intestinal barrier, Intestinal liver axis, Traditional Chinese medicine treatment, Research progress

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases, including fatty liver and nonalcoholic steatohepatitis (NASH), and may develop into more severe liver cirrhosis and even liver cancer. Intestinal barrier can prevent harmful substances such as bacteria and endotoxin from passing through intestinal mucosa and blood circulation, thus affecting the occurrence and development of NAFLD. At present, it has been found that traditional Chinese medicine can regulate the intestinal flora to produce a better effect on NAFLD based on the regulation of intestinal barrier function, and TCM "liver and spleen theory" is closely related to it. By consulting the literature, this paper summarizes the research progress of traditional Chinese medicine based on intestinal barrier in non-alcoholic fatty liver disease in recent years. The regulation of intestinal flora with traditional Chinese medicine has a broad application prospect in the treatment of non-alcoholic fatty liver, which can be used as a reference for doctors.

References

Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, Ouatu A, Floria M. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD) [J]. J Diabetes Res. 2020 Jul 31;2020:3920196.

Fatty Liver and Alcoholic Liver Disease Group, Chinese Society of Hepatology, Fatty Liver Disease Expert Committee of Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease:a 2018 update [J]. Journal of Clinical Hepatology, 2018, 34(5):947-957.

Li S, Han W, He Q, Zhang W, Zhang Y. Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut-Liver Axis Theory [J]. Contrast Media Mol Imaging, 2022, 2022:6533628.

Fang J, Yu CH, Li XJ, Yao JM, Fang ZY, Yoon SH, Yu WY. Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications [J]. Front Cell Infect Microbiol, 2022, 12:997018.

Rebelos E, Iozzo P, Guzzardi MA, Brunetto MR, Bonino F. Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease [J]. World J Gastroenterol, 2021, 27(30):4999-5018.

Cheng Yue, Yu Man, Wang Caixia. Discussion on the essence of intestinal microecology in traditional Chinese medicine under the guidance of spleen and stomach theory [J]. Lishizhen Medicine and Materia Medica Research, 2020, 31(08): 1946-1949.

ZHANG Chen-yang, LIU Tian-hao, WANG Wei, et al. Discussion on intestinal microenvironment as an important biological basis for the theory of treating liver disease from the spleen [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2019, 34(7): 2877-2880.

Zhang Yudan. Based on the theory of "gut-brain axis", to explore the mechanism of Guben Jiannao liquid regulating Aβ deposition and preventing and treating AD [D]. Hubei University of traditional Chinese Medicine, 2021.

Mu Jie, Wang Qingguo, Wang Xueqian, et al. Discussion on the pathogenesis of non-alcoholic fatty liver disease caused by liver depression and phlegm [J]. Global Traditional Chinese Medicine, 2017, 10(1):34-36.

WAN Yong, LIN Yunhua. Treatment of Nonalcoholic Fatty Liver Disease from Kidney [J]. Guangming Journal Of Chinese Medicine, 2019, 34(5): 683-685.

Han Benli. The efficacy of metformin combined with berberine hydrochloride in the treatment of nonalcoholic fatty liver and its effect on the levels of interleukin-17 and transforming growth factor-β [J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2017, 26(5):496-499.

Li Donghao. Protective effect of berberine Hydrochloride on intestinal Mucosal Barrier in NAFLD Rats [D]. Shijiazhuang: Hebei Medical University, 2015.

HUANG G, YE L, DU G, et al. Effects of curcumin plus Soy oligosaccharides on intestinal flora of rats with ulcerative colitis [J]. Cell Mol Biol (Noisy -le- grand), 2017, 63(7): 2025.

JIN Jun, LIU Ji-xiang, YI Ming. Protective effect of berberine against hepatic lipid toxicity induced by high-fat diet in NAFLD mice and its related mechanism [J]. Journal of Clinical and Experimental Medicine, 2019, 18(11):1124-1128.

ZHANG Yuanyuan; YAN Junjun; ZHANG Pei, et al. Berberine Maintains Gut Microbiota Homeostasis and Ameliorates Liver Inflammation in Experimental Nonalcoholic Fatty Liver Disease [J]. Chinese Journal of Gastroenterology, 2018, 23(4):209-215.

MEI L, TANG Y C, LI M, et al. Co-administration of cholesterol-lowering probiotics and anthraquinone from Cassia obtusifolia L. ameliorate non-alcoholic fatty liver [J]. PLoS One, 2015, 10(9): 1371-1378.

Wang Xingzhang. Clinical and experimental study of Zhongmanfanxiao pills in the treatment of non-alcoholic fatty liver disease [D]. Tianjin: Tianjin University of traditional Chinese Medicine, 2016.

Fang Jing. Study on the mechanism of rhubarb Zexie decoction in treating NAFLD based on the effect of intestinal flora on intestinal mucosal mechanical barrier [D]. Nanjing: Nanjing University of traditional Chinese Medicine, 2018.

Yin Xiaochen. Effect of Qushi Huayu recipe on intestinal flora structure in rats with non-alcoholic fatty liver disease [D]. Shanghai: Shanghai Jiaotong University, 2012.

YIN X C, PENG J H, ZHAO L P, et al. Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal For Mula [J]. Syst Appl Microbiol, 2013, 36(3): 188-196.

Li Hongshan, Feng Qin, Zhu Dedong, et al. Clinical Observation on Qushi Huayu Decoction for 82 Cases of Non-Alcoholic Steatohepatitis with Phlegm-Stasis Accumulation Syndrome [J]. Chinese Archives of Traditional Chinese Medicine, 2013, 31(8):1764-1767.

LIU Yue. Effects of Modified Yinchenhao Decoction on Intestinal Microecology in Patients with NAFLD of Damp-Heat Syndrome [J]. Liaoning Journal of Traditional Chinese Medicine2021, 48(3):115-118.

Fang Jing. Study on the mechanism of rhubarb alisma decoction in treating NAFLD based on the effect of intestinal flora on intestinal mucosal mechanical barrier [D]. Nanjing: Nanjing University of traditional Chinese Medicine, 2018.

Cui Xiang. Study on the mechanism of Xiaozhi Yigan recipe in the prevention and treatment of non-alcoholic fatty liver disease induced by high-fat diet in rats [D]. Wuhan: Hubei University of traditional Chinese Medicine, 2017.

Chen Bin, Xu Jiawei, Peng Jie, et al. Effect of 'treating liver by nourishing spleen'on gut microbiota in rats with liver fibrosis based on Xiaoyao powder and its separated recipe [J]. Journal of Clinical Hepatology, 2016, 32(4): 657-662

Yao Zheng, Lin Da, Cao Lu, et al. Effect of Shenling Jianpiwei granule on the expression of UCP-2 and Cytb in liver of mice with non-alcoholic fatty liver disease [J]. Lishizhen Medicine and Materia Medica Research, 2019, 30(10):2330-2333.

Li Ying, Yue Weiyun, Shen Tianbai. Effect of 'Yiqi Qinghua Decoction'on intestinal flora in non-alcoholic fatty liver disease rats [J]. Shanghai Journal of Traditional Chinese Medicine, 2015, 49(8):79-83.

FEI Ya-jun, FEI Xuan, Shenshu. 57 Points with Electro-acupuncture Treatment for NAFLD and Its Influence to Liver CT [J]. Journal of Clinical Acupuncture and Moxibustion, 2018, 34(3):58-61.

Liang Mei. Regulatory effect of acupuncture on intestinal flora in patients with simple obesity [D]. Nanning: Guangxi University of traditional Chinese Medicine, 2016.

Downloads

Published

2024-11-28

How to Cite

Yang, S., & Kou, X. (2024). Research Progress of Intestinal Microflora Regulated by Traditional Chinese Medicine in the Treatment of Non-alcoholic Fatty Liver. Journal of Contemporary Medical Practice, 6(11), 48–52. https://doi.org/10.53469/jcmp.2024.06(11).10